MedTrace Logo

A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males

NCT02067260 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-02-20

No results posted yet for this study

Summary

The overall purpose of this clinical investigation is to collect data to support a marketing application for over the counter use of the X5 HairLaser with an indication for hair growth. The goal of this protocol is to demonstrate that the intended users of the X5 HairLaser can safely and effectively perform self-use application by following written instructions.

Conditions

Interventions

DEVICE

X5 HairLaser

Treatment consists of three, 10-15 minute, at-home treatments per week (on nonconcurrent days) for 26 weeks.

DEVICE

X5 Hair Laser Sham Device

Treatment consists of three, 10-15 minute, at-home treatments per week (on nonconcurrent days) for 26 weeks.

Sponsors & Collaborators

  • Spencer Forrest, Inc.

    lead INDUSTRY

Study Design

Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Primary Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02067260 on ClinicalTrials.gov